Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
162,291
Price
$0.60
Total Value
$96.92K
Shares Held After
2,211,757
% of Holdings
6.8%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
143,709
Price
$0.60
Total Value
$85.82K
Shares Held After
1,958,509
% of Holdings
6.8%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
9,189
Price
$19.50
Total Value
$179.16K
Shares Held After
65,837
% of Holdings
12.2%
Vanda Pharmaceuticals Inc. (VNDA)
Honore Tage — Director
Shares
30,000
Price
$8.03
Total Value
$240.90K
Shares Held After
93,469
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
5,065
Price
$472.13
Total Value
$2.39M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
9,375
Price
$472.13
Total Value
$4.43M
Shares Held After
0
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
587,390
Price
$27.51
Total Value
$16.16M
Shares Held After
13,736,547
% of Holdings
4.1%
Rallybio Corp (RLYB)
Lieber Jonathan I — Chief Financial Officer
Shares
789
Price
$5.06
Total Value
$3.99K
Shares Held After
4,115
% of Holdings
16.1%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
10,000
Price
$9.25
Total Value
$92.50K
Shares Held After
3,081,604
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
2,195
Price
$18.03
Total Value
$39.58K
Shares Held After
337,059
% of Holdings
0.6%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
3,510
Price
$7.74
Total Value
$27.17K
Shares Held After
314,907
% of Holdings
1.1%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
277,769
Price
$0.61
Total Value
$170.80K
Shares Held After
2,374,048
% of Holdings
10.5%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
245,965
Price
$0.61
Total Value
$151.24K
Shares Held After
2,102,218
% of Holdings
10.5%
OCULAR THERAPEUTIX, INC (OCUL)
LINDSTROM RICHARD L MD — Director
Shares
60,229
Price
$7.66
Total Value
$461.35K
Shares Held After
246,933
% of Holdings
24.4%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
30,789
Price
$35.46
Total Value
$1.09M
Shares Held After
53,500
% of Holdings
36.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
14,692
Price
$35.00
Total Value
$514.22K
Shares Held After
84,289
% of Holdings
14.8%
RIGEL PHARMACEUTICALS INC (RIGL)
MOOS WALTER H — Director
Shares
4,000
Price
$36.36
Total Value
$145.44K
Shares Held After
12,722
% of Holdings
23.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
60,000
Price
$30.10
Total Value
$1.81M
Shares Held After
432,886
% of Holdings
12.2%
ARDELYX, INC. (ARDX)
Bishop John E — See Remarks
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
339,151
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Bishop John E — See Remarks
Shares
386
Price
$5.71
Total Value
$2.21K
Shares Held After
339,152
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Bishop John E — See Remarks
Shares
2,792
Price
$5.87
Total Value
$16.38K
Shares Held After
339,538
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
247
Price
$5.71
Total Value
$1.41K
Shares Held After
230,533
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,786
Price
$5.87
Total Value
$10.47K
Shares Held After
230,780
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Reilly Joseph James — See Remarks
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
151,790
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Reilly Joseph James — See Remarks
Shares
602
Price
$5.71
Total Value
$3.44K
Shares Held After
151,792
% of Holdings
0.4%
ARDELYX, INC. (ARDX)
Reilly Joseph James — See Remarks
Shares
4,387
Price
$5.87
Total Value
$25.73K
Shares Held After
152,394
% of Holdings
2.8%
ARDELYX, INC. (ARDX)
MOTT DAVID M — Director
Shares
333,333
Price
$5.84
Total Value
$1.95M
Shares Held After
3,302,918
% of Holdings
10.1%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
1,856,986
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
1,856,988
% of Holdings
0.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
1,012,610
Price
$27.15
Total Value
$27.49M
Shares Held After
13,736,547
% of Holdings
6.9%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
1,856,989
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
5,576
Price
$5.71
Total Value
$31.86K
Shares Held After
1,856,991
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
40,401
Price
$5.87
Total Value
$236.95K
Shares Held After
1,862,567
% of Holdings
2.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
309
Price
$5.71
Total Value
$1.77K
Shares Held After
262,912
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
2,234
Price
$5.87
Total Value
$13.10K
Shares Held After
263,221
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
2
Price
$5.71
Total Value
$11.41
Shares Held After
364,666
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Williams Laura A — See Remarks
Shares
984
Price
$5.71
Total Value
$5.62K
Shares Held After
436,082
% of Holdings
0.2%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
1,159
Price
$5.71
Total Value
$6.62K
Shares Held After
364,668
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Williams Laura A — See Remarks
Shares
7,192
Price
$5.87
Total Value
$42.18K
Shares Held After
437,066
% of Holdings
1.6%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
8,434
Price
$5.87
Total Value
$49.47K
Shares Held After
365,827
% of Holdings
2.3%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
425,970
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1
Price
$5.71
Total Value
$5.71
Shares Held After
425,971
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1,261
Price
$5.71
Total Value
$7.21K
Shares Held After
425,972
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
9,176
Price
$5.87
Total Value
$53.82K
Shares Held After
427,233
% of Holdings
2.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.48
Total Value
$147.79K
Shares Held After
1,804,186
% of Holdings
5.5%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
9,920
Price
$17.86
Total Value
$177.17K
Shares Held After
25,000
% of Holdings
39.7%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$88.10
Total Value
$52.86K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,900
Price
$87.06
Total Value
$165.41K
Shares Held After
600
% of Holdings
76.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
1,400,000
Price
$27.42
Total Value
$38.39M
Shares Held After
13,736,547
% of Holdings
9.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
10,834
Price
$262.10
Total Value
$2.84M
Shares Held After
78,691
% of Holdings
12.1%
Showing 201–250 of 936 transactions (page 5 of 19)